Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,862,300 | 1,380,033 | 1,266,686 | 898,573 | 977,062 |
| Depreciation Amortization | 531,700 | 365,648 | 358,933 | 355,744 | 427,961 |
| Income taxes - deferred | -245,100 | -116,900 | 153,576 | -81,410 | -137,351 |
| Accounts receivable | -126,700 | 3,571 | -73,374 | -99,227 | -100,442 |
| Other Working Capital | 87,500 | 103,728 | -184,612 | 3,559 | -351,482 |
| Other Operating Activity | 235,400 | 143,817 | 206,532 | 547,434 | 259,150 |
| Operating Cash Flow | $2,345,100 | $1,879,897 | $1,727,741 | $1,624,673 | $1,074,898 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 29,991 |
| PPE Investments | -246,300 | -254,548 | -208,020 | -173,055 | -165,646 |
| Net Acquisitions | -15,000 | -72,401 | -5,000 | -157,428 | N/A |
| Purchase Of Investment | -3,278,100 | -3,334,434 | -3,696,995 | -1,992,886 | -3,592,205 |
| Sale Of Investment | 5,190,100 | 2,749,558 | 2,276,720 | 2,668,694 | 3,332,829 |
| Purchase Sale Intangibles | -3,262,700 | 0 | N/A | 0 | N/A |
| Other Investing Activity | -3,255,400 | -38,517 | -16,999 | 0 | 0 |
| Investing Cash Flow | $-1,604,700 | $-950,342 | $-1,650,294 | $345,325 | $-395,031 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 12,275 |
| Debt Repayment | -452,400 | -2,428 | -11,459 | -18,073 | -10,867 |
| Common Stock Issued | 66,800 | 67,493 | 314,650 | 183,486 | 47,810 |
| Common Stock Repurchased | -400,300 | -984,715 | -497,975 | -2,077,579 | -751,170 |
| Other Financing Activity | 69,400 | 42,172 | -125,078 | 127,247 | -22,199 |
| Financing Cash Flow | $-716,500 | $-877,478 | $-319,862 | $-1,784,919 | $-724,151 |
| Exchange Rate Effect | 8,000 | 4,102 | -2,641 | -7,370 | 3,788 |
| Beginning Cash Position | 570,700 | 514,542 | 759,598 | 581,889 | 622,385 |
| End Cash Position | 602,600 | 570,721 | 514,542 | 759,598 | 581,889 |
| Net Cash Flow | $31,900 | $56,179 | $-245,056 | $177,709 | $-40,496 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,345,100 | 1,879,897 | 1,727,741 | 1,624,673 | 1,074,898 |
| Capital Expenditure | -246,300 | -254,548 | -208,020 | -173,055 | -165,646 |
| Free Cash Flow | 2,098,800 | 1,625,349 | 1,519,721 | 1,451,618 | 909,252 |